Switch theme
Sign up to access all valuation multiples
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company’s revenues arise from operations in Argentina.
2022
52
LTM Revenue $6.1M
Last FY EBITDA -$6.2M
$52.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Moolec Science has a last 12-month revenue (LTM) of $6.1M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Moolec Science achieved revenue of $5.6M and an EBITDA of -$6.2M.
Moolec Science expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Moolec Science valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $6.1M | XXX | $5.6M | XXX | XXX | XXX |
| Gross Profit | $1.0M | XXX | $0.5M | XXX | XXX | XXX |
| Gross Margin | 16% | XXX | 8% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | -$6.2M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -110% | XXX | XXX | XXX |
| EBIT | -$9.0M | XXX | -$9.0M | XXX | XXX | XXX |
| EBIT Margin | -148% | XXX | -161% | XXX | XXX | XXX |
| Net Profit | -$7.3M | XXX | -$7.3M | XXX | XXX | XXX |
| Net Margin | -119% | XXX | -130% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $8.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Moolec Science's stock price is $8.
Moolec Science has current market cap of $32.0M, and EV of $52.2M.
See Moolec Science trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $52.2M | $32.0M | XXX | XXX | XXX | XXX | $-1.90 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Moolec Science has market cap of $32.0M and EV of $52.2M.
Moolec Science's trades at 16.0x EV/Revenue multiple, and -1.8x EV/EBITDA.
Equity research analysts estimate Moolec Science's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Moolec Science has a P/E ratio of -4.4x.
See valuation multiples for Moolec Science and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $32.0M | XXX | $32.0M | XXX | XXX | XXX |
| EV (current) | $52.2M | XXX | $52.2M | XXX | XXX | XXX |
| EV/Revenue | 8.5x | XXX | 16.0x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -1.8x | XXX | XXX | XXX |
| EV/EBIT | -5.8x | XXX | -1.8x | XXX | XXX | XXX |
| EV/Gross Profit | 53.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | -4.4x | XXX | -1.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -6.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMoolec Science's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Moolec Science's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Moolec Science's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Moolec Science and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 11% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 32% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 169% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Oatly | XXX | XXX | XXX | XXX | XXX | XXX |
| Beyond Meat | XXX | XXX | XXX | XXX | XXX | XXX |
| Oatly | XXX | XXX | XXX | XXX | XXX | XXX |
| Ingredion | XXX | XXX | XXX | XXX | XXX | XXX |
| Local Bounti | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Moolec Science acquired XXX companies to date.
Last acquisition by Moolec Science was XXXXXXXX, XXXXX XXXXX XXXXXX . Moolec Science acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Moolec Science founded? | Moolec Science was founded in 2022. |
| Where is Moolec Science headquartered? | Moolec Science is headquartered in United States of America. |
| How many employees does Moolec Science have? | As of today, Moolec Science has 52 employees. |
| Who is the CEO of Moolec Science? | Moolec Science's CEO is Mr. Gaston Paladini. |
| Is Moolec Science publicy listed? | Yes, Moolec Science is a public company listed on NAS. |
| What is the stock symbol of Moolec Science? | Moolec Science trades under MLEC ticker. |
| When did Moolec Science go public? | Moolec Science went public in 2023. |
| Who are competitors of Moolec Science? | Similar companies to Moolec Science include e.g. Oatly, Beyond Meat, Oatly, Ingredion. |
| What is the current market cap of Moolec Science? | Moolec Science's current market cap is $32.0M |
| What is the current revenue of Moolec Science? | Moolec Science's last 12 months revenue is $6.1M. |
| What is the current EV/Revenue multiple of Moolec Science? | Current revenue multiple of Moolec Science is 8.5x. |
| Is Moolec Science profitable? | Yes, Moolec Science is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
